Skip to main content

Canada's Largest Cannabis LPs Up 26%, On Average, MTD

The implementation of cannabis as a lower risk Schedule III substance in the U.S. would allow foreign companies to begin selling their products there and that possibility has seen Canadian LPs jump dramatically in price.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.